Features
At Spectrum Medical Imaging Co., we deliver trusted medical imaging services and advanced Gadolinium-Based Contrast Agents to support accurate diagnostics and exceptional patient care.
As a leading contrast media supplier, we provide reliable access to GUERBET ELUCIREM 7.5ML VIAL 10/BX 4231-2 for high-performance magnetic resonance imaging.
GUERBET ELUCIREM 7.5ML VIAL 10/BX 4231-2 is a high-performance, gadolinium-based contrast agent developed to elevate the clarity and diagnostic precision of magnetic resonance imaging (MRI). It plays a vital role in supporting advanced medical imaging services across multiple clinical specialties.
By providing superior contrast enhancement, Elucirem empowers healthcare professionals to perform confident, detail-rich evaluations and contribute to more accurate patient diagnoses.
The GUERBET ELUCIREM 7.5ML VIAL 10/BX is supplied in a convenient 7.5 mL vial format, intended for intravenous injection during MRI scans. Containing gadopiclenol, this agent enhances imaging of vascular lesions across multiple body regions and helps clinicians better detect and characterize abnormalities in medical imaging procedures.
ELUCIREM supports the needs of healthcare providers conducting advanced contrast-enhanced MRI of the brain, spine, and body. Its broad application across body systems allows for better diagnostic outcomes and reinforces a commitment to high-quality patient care in medical imaging services.
Selecting GUERBET ELUCIREM 7.5ML VIAL 10/BX 4231-2 brings several practical and clinical advantages to your facility’s medical imaging services. This formulation supports operational efficiency, clinical precision, and integration with advanced technology.
By offering flexibility, efficiency, and easy implementation, Elucirem supports the performance of your imaging department while maintaining high standards in diagnostic care.
Choosing Spectrum Medical Imaging Co. as your contrast media supplier for GUERBET ELUCIREM 7.5ML VIAL 10/BX 4231-2 means partnering with a dedicated provider focused on your operational success and patient care goals.
With 40 years of experience, Spectrum Medical Imaging Co. understands the challenges healthcare facilities face, from managing high costs to ensuring reliable supply chains for essential medical imaging equipment and supplies.
Elevate your diagnostic precision with GUERBET ELUCIREM 7.5ML VIAL 10/BX 4231-2, available through Spectrum Medical Imaging Co. As a trusted contrast media supplier, we provide fast, reliable access to the industry’s most advanced gadolinium-based contrast agents, backed by 40 years of experience in supporting high-performing medical imaging services.
Contact us today to request a quote, schedule a consultation, or streamline your ordering process with a supplier who understands the demands of modern magnetic resonance imaging and patient-centered care.
ELUCIREM gadopiclenol injection is a next-generation gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to improve the visibility of internal structures and vascular abnormalities. It is administered via intravenous injection and plays a vital role in medical imaging procedures, helping healthcare professionals obtain clearer, more accurate diagnostic images across the CNS, spine, and body.
ELUCIREM administration is approved for use in both adult and pediatric patients aged 2 years and older. It is especially beneficial for high-risk patients and patients at risk, including those undergoing evaluations for neurological or vascular conditions. Healthcare providers assess each patient’s medical history to minimize potential risk and ensure the safest application during medical imaging services.
ELUCIREM offers high relaxivity at a lower gadolinium dose, improving image quality while reducing overall exposure. Unlike traditional gadolinium contrast agents, ELUCIREM supports enhanced diagnostic precision with reduced risk. It delivers clear results in T1-weighted MRI sequences and integrates easily with modern medical imaging equipment, supporting advanced workflows in both MRI and CT imaging environments.
Like all gadolinium-based contrast media, ELUCIREM may present adverse reactions in rare cases, such as nausea, headache, or localized discomfort at the intravenous injection site. Healthcare professionals are trained to monitor patients closely and manage any potential risk, especially in patients at risk for hypersensitivity or impaired renal function. Overall, ELUCIREM has a favorable safety profile when administered according to clinical guidelines.
